.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Citi
Federal Trade Commission
Baxter
Fuji
Express Scripts
UBS
Healthtrust
Argus Health
Merck

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,585,955

« Back to Dashboard

Details for Patent: 6,585,955

Title: Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
Abstract:One can impart outstanding resistance against collapse under pressure to gas-filled microvesicle used as contrast agents in ultrasonic echography by using as fillers gases whose solubility in water, expressed in liter of gas by liter of water under standard conditions, divided by the square root of the molecular weight does not exceed 0.003.
Inventor(s): Schneider; Michel (Troinex, CH), Yan; Feng (Geneva, CH), Grenier; Pascal (late of Ambilly, FR), Puginier; Jerome (Valleiry, FR), Barrau; Marie-Bernadette (Geneva, CH)
Assignee: Bracco International B.V. (Amsterdam, NL)
Filing Date:Oct 31, 1996
Application Number:08/740,653
Claims:1. A contrast agent for ultrasonic echography having an improved resistance to pressure variations comprising, as a suspension in an aqueous carrier liquid, microballoons consisting of a freon gas bounded by an organic polymer envelope made from denatured serum albumin.

2. A contrast agent for ultrasonic echography having an improved resistance to pressure variations comprising, as a suspension in an aqueous carrier liquid, microballoons consisting of a freon gas bubble encapsulated by an organic polymer envelope made from denatured serum albumin.

3. A contrast agent for ultrasonic echography having an improved resistance to pressure variations comprising, as a suspension in an aqueous carrier liquid, microballoons comprising a freon gas bubble encapsulated by an organic polymer envelope made from denatured serum albumin, said envelope being in contact only with the gas and the aqueous carrier liquid.

4. A contrast agent for ultrasonic echography having resistance to pressure variations comprising: a) a plurality of polymeric structures, each polymeric structure consisting of denatured serum albumin in a hollow microballoon form, b) a freon gas that is contained within the hollow microballoon form, and c) an aqueous pharmaceutical formulation for injection.

5. A contrast agent for ultrasonic echography having resistance to pressure variations comprising: a) a plurality of polymeric structures, each polymeric structure consisting of denatured serum albumin, b) a freon gas that is contained within the polymeric structure, and c) an aqueous pharmaceutical formulation for injection.

6. A contrast agent for ultrasonic echography comprising, as a suspension in an aqueous carrier liquid, microballoons consisting of a gas comprising a halogenated hydrocarbon bounded by an organic polymer envelope made from denatured serum albumin.

7. A contrast agent for ultrasonic echography comprising, as a suspension in an aqueous carrier liquid, microballoons consisting of a gas bubble comprising a halogenated hydrocarbon encapsulated by an organic polymer envelope made from denatured serum albumin.

8. A contrast agent for ultrasonic echography comprising, as a suspension in an aqueous carrier liquid, microballoons consisting of a gas bubble comprising a halogenated hydrocarbon encapsulated by an organic polymer envelope made from denatured serum albumin, said envelope being in contact only with the gas and the aqueous carrier liquid.

9. A contrast agent for ultrasonic echography having resistance to pressure variations comprising: a) a plurality of polymeric structures, each polymeric structure consisting of denatured serum albumin in a hollow microballoon form, b) gas comprising a halogenated hydrocarbon that is contained within the hollow microballoon form, and c) an aqueous pharmaceutical formulation for injection.

10. A contrast agent for ultrasonic echography comprising: a) a plurality of polymeric structures, each polymeric structure consisting of denatured serum albumin, b) gas comprising a halogenated hydrocarbon that is contained within the polymeric structure, and c) an aqueous pharmaceutical formulation for injection.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Merck
Daiichi Sankyo
Argus Health
AstraZeneca
Chubb
Cantor Fitzgerald
Healthtrust
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot